SMARTDM2 13.1.0

The management of outpatient antihyperglycemic regimens for patients with type 2 diabetes presents significant complexities. This application aims to consolidate treatment pathway guidelines established by reputable organizations, including the American Diabetes Association, the American Association of Clinical Endocrinologists, and the Emory University Diabetes Council. By allowing users to input patient-specific factors, the app generates a prioritized list of medication options tailored to individual needs.

Intended for use by healthcare professionals, this app operates independently of and has not received endorsement from the American Diabetes Association, the American Association of Clinical Endocrinologists, or the American College of Endocrinology. It is crucial to note that the results generated by the app should not be interpreted as medical advice. Various patient-specific factors not integrated into the app may significantly influence management decisions. Furthermore, clinical evidence and guidelines are subject to change prior to software updates, and unintentional errors may exist within the app. Users are strongly encouraged to consult with a healthcare provider before implementing any changes to a patient’s medication regimen.